If you completed our previous binge eating study, you're invited to continue your treatment journey with us. This next phase lets you keep accessing medication that may help reduce binge eating episodes, with close medical support every step of the way. You'll be part of important research that helps us understand how to best support people like you long-term.
We're continuing to study how solriamfetol works for binge eating disorder over the long term. If you completed our previous study, we'd like you to keep receiving treatment while we monitor your progress and safety through regular visits. Your partnership helps us learn what truly helps people manage binge eating sustainably.
Contact us directly:
Phone: +1 657 230 7120
We're testing an investigational medication called SP-624 to help reduce depression symptoms. You'll receive either SP-624 or a placebo while being monitored closely by our caring team. This research could lead to better treatment options for people living with depression.
Learn MoreAre you or a loved one experiencing agitation related to Alzheimer's disease? This research study is testing a new oral medication called BMS-986368 to help reduce agitation and improve quality of life. We're looking for participants ages 55-90 to join us in this important work.
Learn MoreLiving with ulcerative colitis while managing your weight can feel overwhelming. We're testing a combination approach that may help calm your UC symptoms while supporting meaningful weight loss—giving you the chance to feel better in two important ways.
Learn More